Westaim Corporation reported a smaller loss in the second quarter of 2025, as growth in its asset management business helped offset one-time restructuring expenses tied to its strategic overhaul, as it prepares to launch its insurance arm.
Ceres Life, Westaim’s insurance arm, has obtained necessary licenses and regulatory approvals and received a financial strength rating of B++ from AM Best. The insurer is set to launch in early September through its distribution partnership with Advisors Excel. Arena, the group’s asset management platform, added $1.2 billion in new mandates during the quarter and has begun managing Ceres Life’s investment portfolio
The company posted a net loss attributable to controlling interests of $200,000, or $0.01 per diluted share, compared with a $17.1 million loss, or $0.80 per share, in the same quarter last year.
Assets under management and programatic capital in the asset management segment increased by $1.2 billion during the quarter, reflecting both a previously disclosed $700 million mandate that began on April 1, and an additional $500 million in incremental mandates, including $300 million for its insurance operations.
Westaim’s restructuring weighed on results, with $4.5 million in severance costs booked in Q2. The company said these cuts are expected to deliver annualized run-rate savings of about $4 million. Management also identified another $5 million in potential savings within the asset management unit, bringing total targeted cost reductions to $9 million per year.
As of June 30, 2025, shareholders’ equity attributable to controlling interests stood at $686.4 million. The company said its recent strategic transaction reduced book value per share by $1.48 (C$2.08).
Relative to peers, Westaim's performance appears steadier. Brookfield Asset Management and Onex both reported slower fundraising and weaker fee-related earnings this year as institutional investors pulled back amid higher interest rates.
In the insurance sector, Fairfax Financial and Manulife have leaned on established global platforms to generate profits, while newer entrants have faced heavy start-up costs and regulatory barriers. Against that backdrop, Westaim's ability to attract $1.2 billion in fresh mandates and advance the launch of Ceres Life suggests it is carving out a competitive position despite its ongoing restructuring.
The new corporate structure and leadership team are expected to position Westaim for scalable growth across its insurance and investment businesses, though management cautioned that further operational changes and efficiency measures are likely in the months ahead.
